Global Gabapentin Drug Sales Market Report 2021

1 Gabapentin Drug Market Overview

• 1.1 Gabapentin Drug Product Scope
• 1.2 Gabapentin Drug Segment by Type
  • 1.2.1 Global Gabapentin Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Capsule
  • 1.2.3 Tablet
  • 1.2.4 Oral Solution
• 1.3 Gabapentin Drug Segment by Application
  • 1.3.1 Global Gabapentin Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Postherpetic Neuralgia in Adults
  • 1.3.3 Partial Onset Seizures
  • 1.3.4 Others
• 1.4 Gabapentin Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Gabapentin Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Gabapentin Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Gabapentin Drug Price Trends (2016-2027)

2 Gabapentin Drug Estimates and Forecasts by Region

• 2.1 Global Gabapentin Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Gabapentin Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Gabapentin Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Gabapentin Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Gabapentin Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Gabapentin Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Gabapentin Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Gabapentin Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Gabapentin Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Gabapentin Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Gabapentin Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Gabapentin Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Gabapentin Drug Estimates and Projections (2016-2027)

3 Global Gabapentin Drug Competition Landscape by Players

• 3.1 Global Top Gabapentin Drug Players by Sales (2016-2021)
• 3.2 Global Top Gabapentin Drug Players by Revenue (2016-2021)
• 3.3 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2020)
• 3.4 Global Gabapentin Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Gabapentin Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gabapentin Drug Market Size by Type

• 4.1 Global Gabapentin Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Gabapentin Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Gabapentin Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Gabapentin Drug Price by Type (2016-2021)
• 4.2 Global Gabapentin Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Gabapentin Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Gabapentin Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Gabapentin Drug Price Forecast by Type (2022-2027)

5 Global Gabapentin Drug Market Size by Application

• 5.1 Global Gabapentin Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Gabapentin Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Gabapentin Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Gabapentin Drug Price by Application (2016-2021)
• 5.2 Global Gabapentin Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Gabapentin Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Gabapentin Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Gabapentin Drug Price Forecast by Application (2022-2027)

6 North America Gabapentin Drug Market Facts & Figures

• 6.1 North America Gabapentin Drug Sales by Company
  • 6.1.1 North America Gabapentin Drug Sales by Company (2016-2021)
  • 6.1.2 North America Gabapentin Drug Revenue by Company (2016-2021)
• 6.2 North America Gabapentin Drug Sales Breakdown by Type
  • 6.2.1 North America Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Gabapentin Drug Sales Breakdown by Application
  • 6.3.1 North America Gabapentin Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Gabapentin Drug Sales Breakdown by Application (2022-2027)

7 Europe Gabapentin Drug Market Facts & Figures

• 7.1 Europe Gabapentin Drug Sales by Company
  • 7.1.1 Europe Gabapentin Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Gabapentin Drug Revenue by Company (2016-2021)
• 7.2 Europe Gabapentin Drug Sales Breakdown by Type
  • 7.2.1 Europe Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Gabapentin Drug Sales Breakdown by Application
  • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Gabapentin Drug Market Facts & Figures

• 8.1 China Gabapentin Drug Sales by Company
  • 8.1.1 China Gabapentin Drug Sales by Company (2016-2021)
  • 8.1.2 China Gabapentin Drug Revenue by Company (2016-2021)
• 8.2 China Gabapentin Drug Sales Breakdown by Type
  • 8.2.1 China Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Gabapentin Drug Sales Breakdown by Application
  • 8.3.1 China 175 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 175 Sales Breakdown by Application (2022-2027)

9 Japan Gabapentin Drug Market Facts & Figures

• 9.1 Japan Gabapentin Drug Sales by Company
  • 9.1.1 Japan Gabapentin Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Gabapentin Drug Revenue by Company (2016-2021)
• 9.2 Japan Gabapentin Drug Sales Breakdown by Type
  • 9.2.1 Japan Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Gabapentin Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gabapentin Drug Market Facts & Figures

• 10.1 Southeast Asia Gabapentin Drug Sales by Company
  • 10.1.1 Southeast Asia Gabapentin Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Gabapentin Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Gabapentin Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Gabapentin Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Gabapentin Drug Market Facts & Figures

• 11.1 India Gabapentin Drug Sales by Company
  • 11.1.1 India Gabapentin Drug Sales by Company (2016-2021)
  • 11.1.2 India Gabapentin Drug Revenue by Company (2016-2021)
• 11.2 India Gabapentin Drug Sales Breakdown by Type
  • 11.2.1 India Gabapentin Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Gabapentin Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Gabapentin Drug Sales Breakdown by Application
  • 11.3.1 India Gabapentin Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Gabapentin Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gabapentin Drug Business

• 12.1 Pfizer
  • 12.1.1 Pfizer Corporation Information
  • 12.1.2 Pfizer Business Overview
  • 12.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer Gabapentin Drug Products Offered
  • 12.1.5 Pfizer Recent Development
• 12.2 Depomed
  • 12.2.1 Depomed Corporation Information
  • 12.2.2 Depomed Business Overview
  • 12.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Depomed Gabapentin Drug Products Offered
  • 12.2.5 Depomed Recent Development
• 12.3 Apotex
  • 12.3.1 Apotex Corporation Information
  • 12.3.2 Apotex Business Overview
  • 12.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Apotex Gabapentin Drug Products Offered
  • 12.3.5 Apotex Recent Development
• 12.4 Teva
  • 12.4.1 Teva Corporation Information
  • 12.4.2 Teva Business Overview
  • 12.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Teva Gabapentin Drug Products Offered
  • 12.4.5 Teva Recent Development
• 12.5 Acella Pharmaceuticals
  • 12.5.1 Acella Pharmaceuticals Corporation Information
  • 12.5.2 Acella Pharmaceuticals Business Overview
  • 12.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
  • 12.5.5 Acella Pharmaceuticals Recent Development
• 12.6 Taro
  • 12.6.1 Taro Corporation Information
  • 12.6.2 Taro Business Overview
  • 12.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Taro Gabapentin Drug Products Offered
  • 12.6.5 Taro Recent Development
• 12.7 Sun Pharmaceutical
  • 12.7.1 Sun Pharmaceutical Corporation Information
  • 12.7.2 Sun Pharmaceutical Business Overview
  • 12.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
  • 12.7.5 Sun Pharmaceutical Recent Development
• 12.8 Glenmark
  • 12.8.1 Glenmark Corporation Information
  • 12.8.2 Glenmark Business Overview
  • 12.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Glenmark Gabapentin Drug Products Offered
  • 12.8.5 Glenmark Recent Development
• 12.9 Amneal Pharmaceuticals
  • 12.9.1 Amneal Pharmaceuticals Corporation Information
  • 12.9.2 Amneal Pharmaceuticals Business Overview
  • 12.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
  • 12.9.5 Amneal Pharmaceuticals Recent Development
• 12.10 Aurobindo Pharma
  • 12.10.1 Aurobindo Pharma Corporation Information
  • 12.10.2 Aurobindo Pharma Business Overview
  • 12.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
  • 12.10.5 Aurobindo Pharma Recent Development
• 12.11 Zydus Pharmaceuticals
  • 12.11.1 Zydus Pharmaceuticals Corporation Information
  • 12.11.2 Zydus Pharmaceuticals Business Overview
  • 12.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Zydus Pharmaceuticals Gabapentin Drug Products Offered
  • 12.11.5 Zydus Pharmaceuticals Recent Development
• 12.12 Hi-Tech Pharmaceuticals
  • 12.12.1 Hi-Tech Pharmaceuticals Corporation Information
  • 12.12.2 Hi-Tech Pharmaceuticals Business Overview
  • 12.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Products Offered
  • 12.12.5 Hi-Tech Pharmaceuticals Recent Development
• 12.13 Marksans Pharma
  • 12.13.1 Marksans Pharma Corporation Information
  • 12.13.2 Marksans Pharma Business Overview
  • 12.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Marksans Pharma Gabapentin Drug Products Offered
  • 12.13.5 Marksans Pharma Recent Development
• 12.14 Mylan
  • 12.14.1 Mylan Corporation Information
  • 12.14.2 Mylan Business Overview
  • 12.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Mylan Gabapentin Drug Products Offered
  • 12.14.5 Mylan Recent Development
• 12.15 InvaGen Pharmaceuticals
  • 12.15.1 InvaGen Pharmaceuticals Corporation Information
  • 12.15.2 InvaGen Pharmaceuticals Business Overview
  • 12.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 InvaGen Pharmaceuticals Gabapentin Drug Products Offered
  • 12.15.5 InvaGen Pharmaceuticals Recent Development
• 12.16 Alkem Laboratories
  • 12.16.1 Alkem Laboratories Corporation Information
  • 12.16.2 Alkem Laboratories Business Overview
  • 12.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Alkem Laboratories Gabapentin Drug Products Offered
  • 12.16.5 Alkem Laboratories Recent Development
• 12.17 Tris Pharma
  • 12.17.1 Tris Pharma Corporation Information
  • 12.17.2 Tris Pharma Business Overview
  • 12.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Tris Pharma Gabapentin Drug Products Offered
  • 12.17.5 Tris Pharma Recent Development
• 12.18 ACI HealthCare Limited
  • 12.18.1 ACI HealthCare Limited Corporation Information
  • 12.18.2 ACI HealthCare Limited Business Overview
  • 12.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 ACI HealthCare Limited Gabapentin Drug Products Offered
  • 12.18.5 ACI HealthCare Limited Recent Development
• 12.19 Jiangsu Hengrui Medicine
  • 12.19.1 Jiangsu Hengrui Medicine Corporation Information
  • 12.19.2 Jiangsu Hengrui Medicine Business Overview
  • 12.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Products Offered
  • 12.19.5 Jiangsu Hengrui Medicine Recent Development
• 12.20 CSPC Ouyi Pharmaceutical
  • 12.20.1 CSPC Ouyi Pharmaceutical Corporation Information
  • 12.20.2 CSPC Ouyi Pharmaceutical Business Overview
  • 12.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Products Offered
  • 12.20.5 CSPC Ouyi Pharmaceutical Recent Development
• 12.21 Sciegen Pharmaceuticals
  • 12.21.1 Sciegen Pharmaceuticals Corporation Information
  • 12.21.2 Sciegen Pharmaceuticals Business Overview
  • 12.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.21.4 Sciegen Pharmaceuticals Gabapentin Drug Products Offered
  • 12.21.5 Sciegen Pharmaceuticals Recent Development
• 12.22 Epic Pharma
  • 12.22.1 Epic Pharma Corporation Information
  • 12.22.2 Epic Pharma Business Overview
  • 12.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.22.4 Epic Pharma Gabapentin Drug Products Offered
  • 12.22.5 Epic Pharma Recent Development
• 12.23 Lupin Limited
  • 12.23.1 Lupin Limited Corporation Information
  • 12.23.2 Lupin Limited Business Overview
  • 12.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.23.4 Lupin Limited Gabapentin Drug Products Offered
  • 12.23.5 Lupin Limited Recent Development

13 Gabapentin Drug Manufacturing Cost Analysis

• 13.1 Gabapentin Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Gabapentin Drug
• 13.4 Gabapentin Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Gabapentin Drug Distributors List
• 14.3 Gabapentin Drug Customers

15 Market Dynamics

• 15.1 Gabapentin Drug Market Trends
• 15.2 Gabapentin Drug Drivers
• 15.3 Gabapentin Drug Market Challenges
• 15.4 Gabapentin Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List